drugset / Trial / NCT00005981

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

NCT00005981

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have metastatic colorectal cancer.

Timeline

Start
2000-06
Primary completion
2003-11
Completion
2003-11

Drugs

EvaluationDrugModalityDoseRoute
Subject O6-benzylguanine Small molecule Intravenous
Subject carmustine Small molecule Intravenous

Indications